Literature DB >> 6368831

The association of particular types of Proteus with chronic suppurative otitis media.

B W Senior, G Sweeney.   

Abstract

During a period of 12 months, 57 strains of Proteus were isolated from the ears of 38 unrelated patients with chronic suppurative otitis media. Each strain was identified, typed for bacteriocin production and sensitivity, and tested for Dienes compatibility. The majority of the strains (79%) were P. mirabilis; all but one of the remainder were P.vulgaris. Although 19 different bacteriocin production/sensitivity types were found, two rare types, P. mirabilis P7/S5,12 and P. vulgaris P0/S9, were associated with 47% of these infections. This was confirmed by Dienes typing. Patients with bilateral ear disease carried a different strain in each ear. There was no evidence that persistence of infection had arisen because of the development of antibiotic resistance. Although there was some evidence that persistence may have been the result of reinfection, the isolation of these rare types of Proteus from so many patients with chronic suppurative otitis media may indicate that they play an important role in the pathogenesis of the disease. Most of the Proteus isolates were of "non-faecal" types and it is believed that infection had arisen by a route other than the faecal-aural one.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368831     DOI: 10.1099/00222615-17-2-201

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Proteus mirabilis Urease: Unsuspected Non-Enzymatic Properties Relevant to Pathogenicity.

Authors:  Matheus V C Grahl; Augusto F Uberti; Valquiria Broll; Paula Bacaicoa-Caruso; Evelin F Meirelles; Celia R Carlini
Journal:  Int J Mol Sci       Date:  2021-07-04       Impact factor: 5.923

2.  The effect of phylogeographic history on species boundaries: a comparative framework in Hyla tree frogs.

Authors:  Christophe Dufresnes; Matthieu Berroneau; Sylvain Dubey; Spartak N Litvinchuk; Nicolas Perrin
Journal:  Sci Rep       Date:  2020-03-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.